德甲官网中文版

  • INNOVATION
  • <tfoot id='d0xmLr8'></tfoot>

      <legend id='jcYuM'><style id='WzChU3'><dir id='t7pFmt'><q id='RJQYm'></q></dir></style></legend>
      <i id='93O6z'><tr id='Xboms'><dt id='qFh4gF'><q id='J9cP'><span id='w6FS'><b id='wtDCiq'><form id='i9j0Q'><ins id='uBYLkq'></ins><ul id='c0ThNJ'></ul><sub id='GJDD'></sub></form><legend id='KTox04vn'></legend><bdo id='nsLjU'><pre id='1sVdG'><center id='obDsgt'></center></pre></bdo></b><th id='5V7iv8'></th></span></q></dt></tr></i><div id='29xgp1'><tfoot id='Cgg6uob'></tfoot><dl id='RAOUq7P'><fieldset id='FTIF'></fieldset></dl></div>

          <bdo id='IMP47'></bdo><ul id='KSq6l'></ul>

          1. <li id='LMoy'><abbr id='YDfuul'></abbr></li>
          2. INNOVATION
          3. <tfoot id='d0xmLr8'></tfoot>

              <legend id='jcYuM'><style id='WzChU3'><dir id='t7pFmt'><q id='RJQYm'></q></dir></style></legend>
              <i id='93O6z'><tr id='Xboms'><dt id='qFh4gF'><q id='J9cP'><span id='w6FS'><b id='wtDCiq'><form id='i9j0Q'><ins id='uBYLkq'></ins><ul id='c0ThNJ'></ul><sub id='GJDD'></sub></form><legend id='KTox04vn'></legend><bdo id='nsLjU'><pre id='1sVdG'><center id='obDsgt'></center></pre></bdo></b><th id='5V7iv8'></th></span></q></dt></tr></i><div id='29xgp1'><tfoot id='Cgg6uob'></tfoot><dl id='RAOUq7P'><fieldset id='FTIF'></fieldset></dl></div>

                  <bdo id='IMP47'></bdo><ul id='KSq6l'></ul>

                  1. <li id='LMoy'><abbr id='YDfuul'></abbr></li>
                  2. PRODUCTS
                  3. <tfoot id='d0xmLr8'></tfoot>

                      <legend id='jcYuM'><style id='WzChU3'><dir id='t7pFmt'><q id='RJQYm'></q></dir></style></legend>
                      <i id='93O6z'><tr id='Xboms'><dt id='qFh4gF'><q id='J9cP'><span id='w6FS'><b id='wtDCiq'><form id='i9j0Q'><ins id='uBYLkq'></ins><ul id='c0ThNJ'></ul><sub id='GJDD'></sub></form><legend id='KTox04vn'></legend><bdo id='nsLjU'><pre id='1sVdG'><center id='obDsgt'></center></pre></bdo></b><th id='5V7iv8'></th></span></q></dt></tr></i><div id='29xgp1'><tfoot id='Cgg6uob'></tfoot><dl id='RAOUq7P'><fieldset id='FTIF'></fieldset></dl></div>

                          <bdo id='IMP47'></bdo><ul id='KSq6l'></ul>

                          1. <li id='LMoy'><abbr id='YDfuul'></abbr></li>
                          2. CAREER
                          3. <tfoot id='d0xmLr8'></tfoot>

                              <legend id='jcYuM'><style id='WzChU3'><dir id='t7pFmt'><q id='RJQYm'></q></dir></style></legend>
                              <i id='93O6z'><tr id='Xboms'><dt id='qFh4gF'><q id='J9cP'><span id='w6FS'><b id='wtDCiq'><form id='i9j0Q'><ins id='uBYLkq'></ins><ul id='c0ThNJ'></ul><sub id='GJDD'></sub></form><legend id='KTox04vn'></legend><bdo id='nsLjU'><pre id='1sVdG'><center id='obDsgt'></center></pre></bdo></b><th id='5V7iv8'></th></span></q></dt></tr></i><div id='29xgp1'><tfoot id='Cgg6uob'></tfoot><dl id='RAOUq7P'><fieldset id='FTIF'></fieldset></dl></div>

                                  <bdo id='IMP47'></bdo><ul id='KSq6l'></ul>

                                  1. <li id='LMoy'><abbr id='YDfuul'></abbr></li>
                                  2. ACHIEVE SUCCESS TOGETHER
                                  3. <tfoot id='d0xmLr8'></tfoot>

                                      <legend id='jcYuM'><style id='WzChU3'><dir id='t7pFmt'><q id='RJQYm'></q></dir></style></legend>
                                      <i id='93O6z'><tr id='Xboms'><dt id='qFh4gF'><q id='J9cP'><span id='w6FS'><b id='wtDCiq'><form id='i9j0Q'><ins id='uBYLkq'></ins><ul id='c0ThNJ'></ul><sub id='GJDD'></sub></form><legend id='KTox04vn'></legend><bdo id='nsLjU'><pre id='1sVdG'><center id='obDsgt'></center></pre></bdo></b><th id='5V7iv8'></th></span></q></dt></tr></i><div id='29xgp1'><tfoot id='Cgg6uob'></tfoot><dl id='RAOUq7P'><fieldset id='FTIF'></fieldset></dl></div>

                                          <bdo id='IMP47'></bdo><ul id='KSq6l'></ul>

                                          1. <li id='LMoy'><abbr id='YDfuul'></abbr></li>
                                          2. NEWS
                                          3. <tfoot id='d0xmLr8'></tfoot>

                                              <legend id='jcYuM'><style id='WzChU3'><dir id='t7pFmt'><q id='RJQYm'></q></dir></style></legend>
                                              <i id='93O6z'><tr id='Xboms'><dt id='qFh4gF'><q id='J9cP'><span id='w6FS'><b id='wtDCiq'><form id='i9j0Q'><ins id='uBYLkq'></ins><ul id='c0ThNJ'></ul><sub id='GJDD'></sub></form><legend id='KTox04vn'></legend><bdo id='nsLjU'><pre id='1sVdG'><center id='obDsgt'></center></pre></bdo></b><th id='5V7iv8'></th></span></q></dt></tr></i><div id='29xgp1'><tfoot id='Cgg6uob'></tfoot><dl id='RAOUq7P'><fieldset id='FTIF'></fieldset></dl></div>

                                                  <bdo id='IMP47'></bdo><ul id='KSq6l'></ul>

                                                  1. <li id='LMoy'><abbr id='YDfuul'></abbr></li>
                                                    Position: EASTERN ALONG GROUP > PRODUCTS >

                                                    德甲官网中文版: LoDan

                                                    Benazepril Hydrochloride Chewable Tablets

                                                    Trade Name
                                                    LoDan
                                                    Product Name
                                                    Benazepril Hydrochloride Chewable Tablets
                                                     
                                                    Benazeprilat, the active metabolite of benazepril, is a non-sulfhydryl angiotensin-converting enzyme inhibitor. Benazepril is converted to benazeprilat by hepatic cleavage of the ester group.

                                                    Feature
                                                    Rapid absorption
                                                    Wide distribution
                                                    Low toxicity and side effects
                                                    No inhibitory effect on the vasopressor response to angiotensin II
                                                    Has an antihypertensive effect even in patients with low-renin hypertension

                                                    Effective at
                                                    Inhibit angiotensin-converting enzyme (ACE) in cats and dogs
                                                    Decreased plasma angiotensin II in cats and dogs
                                                    Decreased vasopressor activity in cats and dogs
                                                    Decreased aldosterone secretion in cats and dogs
                                                    Inhibited the degradation of bradykinin in cats and dogs
                                                    Lower blood pressure in cats and dogs
                                                    Cats and dogs with low-renin hypertension

                                                    Indicated for
                                                    Treats heart failure, high blood pressure, and some forms of kidney disease in dogs and cats.
                                                    Dilates the veins and decreases fluid retention.

                                                    Usage & Dosage
                                                    Calculate with benazepril hydrochloride. Oral administration, 0.25-0.5mg per 1kg body weight, once daily, or as recommended in the table below.

                                                    Canine body weight(kg)

                                                     5-10

                                                    11-20

                                                    21-40

                                                    41-80

                                                    Dosage

                                                    1/2 tablet

                                                    1 tablet

                                                    2 tablets

                                                    4 tablets

                                                    According to the clinical efficacy, the dosage can be doubled according to the above dosage.

                                                    Precautions
                                                    1.LoDan is contraindicated in dogs that are allergic to angiotensin-converting enzyme inhibitors.
                                                    2.LoDan should be used with caution on cats or dogs with hyponatremia, coronary or vascular insufficiency, congenital hematopathy, or collagen vascular disease. It is not recommended for pregnant or lactating bitches.
                                                    3. When dosing on dogs with severe congestive heart failure, should closely monitor.
                                                    4. When dosing on renal insufficiency dogs, the risk of drug accumulation is  small, do not need to adjust the dose, but it is recommended to test blood urea and creatinine levels.

                                                    Specification
                                                    0.5g:5mg


                                                    Package
                                                    14 tablets/ pack

                                                     

                                                    德甲官网中文版【电子】有限公司